Menu
Your Cart

Apostle MiniGenomics Viral Total NA Isolation Kit (6144 preps), with Plates & Tip Comb Included

Apostle MiniGenomics Viral Total NA Isolation Kit (6144 preps), with Plates & Tip Comb Included
Secured Shopping
Best security features
Apostle MiniGenomics Viral Total NA Isolation Kit (6144 preps), with Plates & Tip Comb Included
  • For fast extraction and purification of viral nucleic acids from various kinds of biological samples collected in multiple transport media.  
  • Novel and original magnetic nanoparticle technology for nucleic acids isolation.   
  • Various sample types: swabs, saliva, blood.   
  • Optimized standardized protocol for viral total NA isolation in 30 min without heating.   
  • Compatible with multiple high-throughput automated nucleic acid extraction platforms.   
  • Configuration: 200uL X 6144 preps (96X64 preps,A200619P-6144).   This kit package includes both reagents and consumables (96-well deep plates and tip combs).
  • Cat #: A200619P-6144.

Documentation:

Product brochure: Apostle-COVID-19-Viral-RNA-Isolation-System.pdf

System protocol: Apostle-MiniGenomics-Viral-Total-NA-Isolation-MagTouch-protocol.pdf

Application Note: Application-Note-Apostle-Viral-RNA-Isolation-System.pdf

This links directs to an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 15 million clinical samples by our clients.

Material Safety Data Sheet (MSDS): Apostle_MiniGenomics_Viral_Total_NA_Isolation_Fast_Kit_Material_Safety_01.pdf



Inclusion in US FDA IVD EUA - Molecular Diagnostic Tests for SARS-CoV-2

Apostle RNA extraction method is included in a US FDA EUA authorized SARS-CoV-2 molecular diagnostic test: Fulgent COVID-19 by RT-PCT Test.

Tags: COVID-19
2024年2月,美国MD Anderson癌症中心科学家团队领衔的一项新临床研究发表在Cell子刊 Cancer Cell (影响因子 50.3),建立了临床证据和方法,使用肿瘤cfDNA 甲基化分析可以有效区分小细胞肺癌(SCLC) 亚型,并用于指导SCLC 治疗方案。 在论著的方法学部分,Apostle MiniMax cfDNA 试剂盒被明确列在“关键商业试剂” (Critical commercial assays)表格中,作出自己应用的贡献。Apostle 艾铂图 MiniMax 游离核酸技术不断在国际上得到广泛的应用,迄今,已发表、被引用 Nature 子刊 4篇 ( Nature Medicine X 2, Nature Communications X 2), Science 子刊 1 篇, PNAS 1 篇,各种临床研究60余篇,作者单位来自60余国际领先的医学研究和临床单位。 祝贺此临床研究团队!期待Apostle 艾铂图技术更好地为人类做贡献。